← Leaderboards
P. Michael Conn
Oregon Health & Science University
$3,852,280
Attributed
$4,628,115
Total exposure
14
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $825.5K · FY2008–16$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,628,115 · 14
By mechanism
R01$3,162,880 · 4
D43$578,321 · 1
R21$475,094 · 2
P51$411,820 · 7
Top collaborators
- Louis Daniel Scampavia3 shared
- Peter Simmons Hodder1 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Bryan W Luikart$6,446,332
- Steven Elias Mansoor$3,441,702
- James Henry Peters$1,763,770
- Alexandra Bowman Pincus$199,570
- Antonia Savarese$151,365
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseUnited States National Institutes Of HealthMutantReceptorFundingProteinsGrantProgramsPharmaceutical PreparationsSourceAgonistProtein MisfoldingPrimatesPrototypeHigh Throughput ScreeningReagentMolecular ChaperonesGonadotropin-Releasing Hormone ReceptorValidationNephrogenic Diabetes InsipidusAnalogSmall Molecule LibrariesHuman DiseaseIn Vivo
Grant awards (22)
Identification of Small Molecules that Influence Trafficking of the GnRH Receptor$514,347
R01 · FY2016 · DK · contact PI
High Throughput Screening for Pharmacoperones of the V2 Receptor$537,413
R01 · FY2014 · DK · contact PI
High Throughput Screening for Pharmacoperones of the V2 Receptor$450,213
R01 · FY2013 · DK · contact PI
High Throughput Screening for Pharmacoperones of the V2 Receptor$49,697
R01 · FY2013 · DK · contact PI
High Throughput Screening Assay Development for Pharmacoperones$241,421
R01 · FY2012 · DK · contact PI
Mouse Model for Diseases of Protein Misfolding$173,866
R21 · FY2012 · OD · contact PI
High Throughput Screening Assay Development for Pharmacoperones$95,476
R01 · FY2012 · DK · contact PI
Mouse Model for Diseases of Protein Misfolding$38,728
R21 · FY2012 · OD · contact PI
High Throughput Screening Assay Development for Pharmacoperones$336,897
R01 · FY2011 · DK · contact PI
Mouse Model for Diseases of Protein Misfolding$262,500
R21 · FY2011 · RR · contact PI
HIGH THROUGHPUT SCREENING ASSAY DEVELOPMENT FOR PHARMACOPERONES$58,239
P51 · FY2011 · RR · contact PI
MOUSE MODEL FOR DISEASES OF PROTEIN MISFOLDING$58,239
P51 · FY2011 · RR · contact PI
GONADOTROPIN-RELEASING HORMONE ACTION$36,286
P51 · FY2011 · RR · contact PI
High Throughput Screening Assay Development for Pharmacoperones$410,000
R01 · FY2010 · DK · contact PI
International Training and Research in Population and Health$198,498
D43 · FY2010 · TW · contact PI
GONADOTROPIN-RELEASING HORMONE ACTION$47,603
P51 · FY2010 · RR · contact PI
International Training and Research in Population and Health$192,717
D43 · FY2009 · TW · contact PI
GONADOTROPIN-RELEASING HORMONE ACTION$100,429
P51 · FY2009 · RR · contact PI
Gonadotropin-Releasing Hormone Action$527,416
R01 · FY2008 · HD · contact PI
International Training and Research in Population and Health$187,106
D43 · FY2008 · TW · contact PI
RESEARCH SERVICES$55,512
P51 · FY2008 · RR · contact PI
GONADOTROPIN-RELEASING HORMONE ACTION$55,512
P51 · FY2008 · RR · contact PI